Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$92.57 - $107.37 $4,350 - $5,046
47 Added 3.34%
1,455 $154,000
Q1 2023

Jul 17, 2024

BUY
$80.03 - $92.81 $2,961 - $3,433
37 Added 2.7%
1,408 $130 Million
Q3 2022

Jul 17, 2024

SELL
$74.61 - $87.26 $1,865 - $2,181
-25 Reduced 1.79%
1,371 $104 Million
Q1 2022

Jul 17, 2024

BUY
$80.11 - $90.62 $2,643 - $2,990
33 Added 2.42%
1,396 $123 Million
Q4 2021

Jul 17, 2024

SELL
$79.7 - $88.13 $1,753 - $1,938
-22 Reduced 1.59%
1,363 $119 Million
Q3 2021

Jul 17, 2024

SELL
$81.78 - $95.14 $10.2 Million - $11.9 Million
-124,949 Reduced 98.9%
1,385 $113 Million
Q2 2021

Jul 17, 2024

BUY
$85.24 - $94.15 $10.7 Million - $11.8 Million
124,949 Added 9021.59%
126,334 $1.39 Million
Q1 2021

Jul 17, 2024

BUY
$83.5 - $98.47 $111,723 - $131,752
1,338 Added 2846.81%
1,385 $118 Million
Q3 2019

Jul 17, 2024

BUY
$85.54 - $94.26 $4,020 - $4,430
47 New
47 $4.08 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.